Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression

Proceedings of the National Academy of Sciences(2024)10.1073/pnas.2317760121Source: DataRank Database

Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression is a research paper published in Proceedings of the National Academy of Sciences (2024). On theSindex it has a DataRank of 0. It has been cited 19 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access19 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 3.33)OA: hybridTopics (72)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Christopher Xie ORCID,Gabriel J. Pascal ORCID,Simone Buraschi ORCID,Renato V. Iozzo ORCID,Dipon Kumar Mondal ORCID

Live enrichment

PubMed:38652741 PMC:PMC11067011 OpenAlex:https://openalex.org/W4395030589

HHS | National Institutes of Health

Grant: RO1 CA39481

HHS | National Institutes of Health

Grant: RO1 CA245311

HHS | National Institutes of Health

Grant: RO3 CA270830

HHS | National Institutes of Health

Grant: 3R01CA245311-04S1

Proteoglycan regulation of tumor angiogenesis and endothelial cell autophagy

NCI NIH HHS

Grant: R01 CA245311

NCI NIH HHS

Grant: R03 CA270830

NCI NIH HHS

Grant: R01 CA039481

National Institutes of Health

Grant: 5R03CA270830-02

Mitostatin-evoked mitophagy for breast cancer inhibition

National Institutes of Health

Grant: 1R01CA039481-01

NEOPLASTIC MODULATION OF PROTEOGLYCAN METABOLISM

FWCI

3.33

Citation Percentile

0.9%

Citation Trend

2024

2025

2026

hybridLicense: cc-by-nc-nd

journalhttps://doi.org/10.1073/pnas.2317760121

HYBRIDhttps://doi.org/10.1073/pnas.2317760121

publisherhttps://doi.org/10.1073/pnas.2317760121

publisherhttps://pnas.org/doi/pdf/10.1073/pnas.2317760121

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38652741

Fields of Study

Lymphatic System and DiseasesAngiogenesis and VEGF in CancerProteoglycans and glycosaminoglycans researchMedicineBiology0301 basic medicine03 medical and health sciences0303 health sciencesDecorinLymphangiogenesisAnimalsMiceHumansFemaleBreast NeoplasmsLymphatic VesselsCell Line, TumorDisease ProgressionVesicular Transport ProteinsMembrane GlycoproteinsGene Expression Regulation, Neoplastic

MeSH Terms

AnimalsBreast NeoplasmsFemaleHumansMembrane GlycoproteinsGene Expression Regulation, NeoplasticDisease ProgressionVesicular Transport ProteinsLymphangiogenesisLymphatic VesselsCell Line, TumorMiceDecorin

Keywords

LymphangiogenesisDecorinMechanism (biology)Cancer researchCancerMedicineMetastasisExtracellular matrixInternal medicineCell biologyBiologyProteoglycanPhilosophyBreast cancerLymphatic vesselsSmall Leucine-rich ProteoglycanVegfr3Ex Vivo Lymphatic Ring AssaytumormiceVesicular Transport Proteins610Breast Neoplasmsmembrane glycoproteinsTherapeuticsdisease progressionNeoplasmsCell Line, TumorAnimalsHumansCancer Biologycell linegene expression regulationBiological Sciences540neoplasticGene Expression Regulation, Neoplasticfemale

Sustainable Development Goals

SDG 0: Good health and well-being